Tudor Investment Corp
ASMB icon

Tudor Investment Corp’s Assembly Biosciences ASMB Stock Holding History

Tudor Investment Corp’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,979
Closed -$314K – 1484
2015
Q1 		$314K Buy
+1,979
New +$268K 0.01% 1021

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Tudor Investment Corp's ASMB Position: Q2 2015 in Review

Tudor Investment Corp sold out of Assembly Biosciences (ASMB) in Q2 2015, closing a stake of 1,979 shares — an estimated $314K sold.

Tudor Investment Corp first reported a position in ASMB in Q1 2015 and held it in 1 quarter. The position peaked at $314K in Q1 2015. 57 funds tracked by Wall St. Rank hold ASMB as of Q2 2015.

  • Tudor Investment Corp reported no remaining Assembly Biosciences position as of Q2 2015 after selling out during the quarter.
  • Tudor Investment Corp sold 1,979 Assembly Biosciences shares in Q2 2015, an estimated $314K.
  • Tudor Investment Corp first reported a position in Assembly Biosciences in Q1 2015 and held it in 1 quarter.
  • Tudor Investment Corp's Assembly Biosciences position peaked at $314K in Q1 2015.
  • 57 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2015.

Based on Tudor Investment Corp's 13F filing for Q2 2015, filed 14 Aug 2015.